GS0091: scientific instrument consisting of computer hardware and software for the automated magnetic separation of biological and non-biological materials; magnetic cell separation equipment, namely, magnetic cell separators for laboratory use; computer software for use in preparing, analyzing, and communicating medical reports; laboratory equipment, namely, laboratory glassware, culture dishes, disposable reusable dispenser syringes for laboratory use, centrifugal metering pumps, controlled volume pumps, high-pressure pumps for proportioning and testing purposes, and wells, namely, plastic trays with depressions; bioreactors, namely, fermentation reactors for cell culturing
GS0051: cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, clinical, or medical diagnostic use; diagnostic reagents for medical and clinical use; antibody complexes for connecting two or more different cell types or substances for medical, clinical or medical diagnostic use
GS0011: cell growth media, tissue culture media, cytokines, antibodies, and reagents for scientific, research or laboratory use; tissue culture media, growth factors, growth media, serum, and nutritional supplements for the in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; antibody complexes for connecting two or more different cell types or substances for scientific, research or laboratory use; cell separation reagents, magnetic cell separation solutions; cell growth media stimulant coatings made of biological materials for use in the growth, expansion, differentiation or manipulation of cells, microorganisms, tissues or organs for laboratory use or research use or use in the manufacturing of biotechnology products; molecular tags, namely, protein complexes, non-biological molecular complexes and magnetic particles for laboratory and scientific use; reagents and kits comprised of reagents, antibodies, protein complexes, non-biological molecular complexes or magnetic particles for labeling antibodies with fluorochromes or other molecules for laboratory and scientific use; reagents that complement bispecific immune complexes comprised of monoclonal antibodies, reagents used to cross-link biological agents such as cells, growth factors, toxins, antigens, viruses and extra cellular matrix molecules; specialized liquid and semi-liquid media and support reagents for growth, cloning or experimental analysis of cells and neurospheres for laboratory and scientific use
GS0421: Medical and scientific research consultation and research and development services all in the fields of hematology, immunology, cancer research, developmental biology, and life science; medical and scientific laboratory services, namely, contract assays services and proficiency testing services for research and development purposes in the fields of hematology, immunology, cancer research, developmental biology, and life science; medical and scientific laboratory services, namely, flow cytometry services; medical and scientific laboratory services, namely, cell-based assay services in the nature of providing immunophenotyping assays, functional assays using primary cells from multiple species, and intracircular and circulating cytokine analysis; medical and scientific laboratory services, namely, providing immunophenotyping assays for whole animal studies
Case File Event Statements
6/2/2023 - a year ago
34 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILEDType:NA85
6/2/2023 - a year ago
33 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
6/2/2023 - a year ago
32 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
11/25/2022 - 2 years ago
31 - TEAS SECTION 8 & 15 RECEIVEDType:E815
12/20/2021 - 3 years ago
30 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
12/20/2016 - 8 years ago
29 - REGISTERED-PRINCIPAL REGISTERType:R.PR
10/4/2016 - 8 years ago
28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
10/4/2016 - 8 years ago
27 - PUBLISHED FOR OPPOSITIONType:PUBO
9/14/2016 - 8 years ago
26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
8/29/2016 - 8 years ago
25 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
8/23/2016 - 8 years ago
24 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
8/22/2016 - 8 years ago
23 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
8/22/2016 - 8 years ago
22 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
8/22/2016 - 8 years ago
21 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
8/11/2016 - 8 years ago
20 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
8/16/2016 - 8 years ago
19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVEDType:ERSI
8/11/2016 - 8 years ago
18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVEDType:ERSI
6/10/2016 - 8 years ago
17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILEDType:GNS2
6/10/2016 - 8 years ago
16 - INQUIRY TO SUSPENSION E-MAILEDType:GNSI
6/10/2016 - 8 years ago
15 - SUSPENSION INQUIRY WRITTENType:CNSI
2/24/2016 - 8 years ago
14 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
11/23/2015 - 9 years ago
13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILEDType:GNS3
11/23/2015 - 9 years ago
12 - LETTER OF SUSPENSION E-MAILEDType:GNSL
11/23/2015 - 9 years ago
11 - SUSPENSION LETTER WRITTENType:CNSL
11/17/2015 - 9 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
11/17/2015 - 9 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
11/10/2015 - 9 years ago
8 - ASSIGNED TO LIEType:ALIE
10/22/2015 - 9 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
4/24/2015 - 9 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
4/24/2015 - 9 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
4/24/2015 - 9 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
4/16/2015 - 9 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
1/22/2015 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS